CATH Superfamily 2.40.50.120
The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was: waiting to be named.
FunFam 6: Secreted frizzled-related protein 2
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 11 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Fibronectin binding GO:0001968
Interacting selectively and non-covalently with a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids.
|
4 | Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) |
Integrin binding GO:0005178
Interacting selectively and non-covalently with an integrin.
|
4 | Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) |
Wnt-protein binding GO:0017147
Interacting selectively and non-covalently with Wnt-protein, a secreted growth factor involved in signaling.
|
4 | Q96HF1 (/NAS) Q96HF1 (/NAS) Q96HF1 (/NAS) Q96HF1 (/NAS) |
Receptor ligand activity GO:0048018
The activity of a gene product that interacts with a receptor to effect a change in the activity of the receptor. Ligands may be produced by the same, or different, cell that expresses the receptor. Ligands may diffuse extracellularly from their point of origin to the receiving cell, or remain attached to an adjacent cell surface (e.g. Notch ligands).
|
4 | Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) |
Fibronectin binding GO:0001968
Interacting selectively and non-covalently with a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids.
|
2 | Q863H1 (/IPI) Q863H1 (/IPI) |
Integrin binding GO:0005178
Interacting selectively and non-covalently with an integrin.
|
2 | Q863H1 (/IDA) Q863H1 (/IDA) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
2 | P97299 (/IPI) P97299 (/IPI) |
Enzyme activator activity GO:0008047
Binds to and increases the activity of an enzyme.
|
2 | P97299 (/IDA) P97299 (/IDA) |
Wnt-protein binding GO:0017147
Interacting selectively and non-covalently with Wnt-protein, a secreted growth factor involved in signaling.
|
2 | P97299 (/IPI) P97299 (/IPI) |
Receptor ligand activity GO:0048018
The activity of a gene product that interacts with a receptor to effect a change in the activity of the receptor. Ligands may be produced by the same, or different, cell that expresses the receptor. Ligands may diffuse extracellularly from their point of origin to the receiving cell, or remain attached to an adjacent cell surface (e.g. Notch ligands).
|
2 | P97299 (/IDA) P97299 (/IDA) |
Endopeptidase activator activity GO:0061133
Increases the activity of an endopeptidase, any enzyme that hydrolyzes nonterminal peptide bonds in polypeptides.
|
2 | P97299 (/IDA) P97299 (/IDA) |
There are 100 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
6 | P97299 (/IDA) P97299 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) |
Negative regulation of Wnt signaling pathway GO:0030178
Any process that stops, prevents, or reduces the frequency, rate or extent of the Wnt signaling pathway.
|
6 | P97299 (/IDA) P97299 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) |
Negative regulation of canonical Wnt signaling pathway GO:0090090
Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
|
6 | P97299 (/IDA) P97299 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) |
Branching involved in blood vessel morphogenesis GO:0001569
The process of coordinated growth and sprouting of blood vessels giving rise to the organized vascular system.
|
4 | Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) |
Outflow tract morphogenesis GO:0003151
The process in which the anatomical structures of the outflow tract are generated and organized. The outflow tract is the portion of the heart through which blood flows into the arteries.
|
4 | Q96HF1 (/IMP) Q96HF1 (/IMP) Q96HF1 (/IMP) Q96HF1 (/IMP) |
Cardiac left ventricle morphogenesis GO:0003214
The process in which the left cardiac ventricle is generated and organized.
|
4 | Q96HF1 (/IMP) Q96HF1 (/IMP) Q96HF1 (/IMP) Q96HF1 (/IMP) |
Cell-cell signaling GO:0007267
Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.
|
4 | Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
4 | Q96HF1 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
4 | Q96HF1 (/IMP) Q96HF1 (/IMP) Q96HF1 (/IMP) Q96HF1 (/IMP) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
4 | Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) |
Negative regulation of epithelial to mesenchymal transition GO:0010719
Any process that decreases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
4 | Q96HF1 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) |
Negative regulation of Wnt signaling pathway GO:0030178
Any process that stops, prevents, or reduces the frequency, rate or extent of the Wnt signaling pathway.
|
4 | Q96HF1 (/NAS) Q96HF1 (/NAS) Q96HF1 (/NAS) Q96HF1 (/NAS) |
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
|
4 | Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) |
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
|
4 | Q96HF1 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) |
Negative regulation of cell migration GO:0030336
Any process that stops, prevents, or reduces the frequency, rate or extent of cell migration.
|
4 | Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) |
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
|
4 | Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) |
Positive regulation of cell adhesion mediated by integrin GO:0033630
Any process that activates or increases the frequency, rate, or extent of cell adhesion mediated by integrin.
|
4 | Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
4 | Q96HF1 (/IMP) Q96HF1 (/IMP) Q96HF1 (/IMP) Q96HF1 (/IMP) |
Positive regulation of fat cell differentiation GO:0045600
Any process that activates or increases the frequency, rate or extent of adipocyte differentiation.
|
4 | Q96HF1 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) |
Positive regulation of angiogenesis GO:0045766
Any process that activates or increases angiogenesis.
|
4 | Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
4 | Q96HF1 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
4 | Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) |
Negative regulation of epithelial cell proliferation GO:0050680
Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation.
|
4 | Q96HF1 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) |
Negative regulation of peptidyl-tyrosine phosphorylation GO:0050732
Any process that stops, prevents, or reduces the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
|
4 | Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) |
Sclerotome development GO:0061056
The progression of the sclerotome over time, from its initial formation to the mature structure. The sclerotome is the portion of the somite that will give rise to a vertebra.
|
4 | Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) |
Negative regulation of dermatome development GO:0061185
Any process that decreases the rate, frequency, or extent of the progression of the dermatome over time, from its initial formation to the mature structure. The dermatome is the portion of a somite that will form skin.
|
4 | Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) |
Hematopoietic stem cell proliferation GO:0071425
The expansion of a hematopoietic stem cell population by cell division. A hematopoietic stem cell is a stem cell from which all cells of the lymphoid and myeloid lineages develop.
|
4 | Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) |
Positive regulation of canonical Wnt signaling pathway GO:0090263
Any process that increases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
|
4 | Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) |
Negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage GO:1902230
Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to DNA damage.
|
4 | Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) |
Regulation of stem cell division GO:2000035
Any process that modulates the frequency, rate or extent of stem cell division.
|
4 | Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) |
Negative regulation of canonical Wnt signaling pathway GO:0090090
Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
|
3 | B1WBV2 (/IGI) P97299 (/IGI) P97299 (/IGI) |
Positive regulation of canonical Wnt signaling pathway GO:0090263
Any process that increases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
|
3 | B1WBV2 (/IGI) P97299 (/IGI) P97299 (/IGI) |
Branching involved in blood vessel morphogenesis GO:0001569
The process of coordinated growth and sprouting of blood vessels giving rise to the organized vascular system.
|
2 | P97299 (/IDA) P97299 (/IDA) |
Somitogenesis GO:0001756
The formation of mesodermal clusters that are arranged segmentally along the anterior posterior axis of an embryo.
|
2 | P97299 (/IGI) P97299 (/IGI) |
Neural tube closure GO:0001843
The last step in the formation of the neural tube, where the paired neural folds are brought together and fuse at the dorsal midline.
|
2 | P97299 (/IGI) P97299 (/IGI) |
Chondrocyte development GO:0002063
The process whose specific outcome is the progression of a chondrocyte over time, from its commitment to its mature state. Chondrocyte development does not include the steps involved in committing a chondroblast to a chondrocyte fate.
|
2 | P97299 (/IMP) P97299 (/IMP) |
Outflow tract morphogenesis GO:0003151
The process in which the anatomical structures of the outflow tract are generated and organized. The outflow tract is the portion of the heart through which blood flows into the arteries.
|
2 | P97299 (/ISO) P97299 (/ISO) |
Cardiac left ventricle morphogenesis GO:0003214
The process in which the left cardiac ventricle is generated and organized.
|
2 | P97299 (/ISO) P97299 (/ISO) |
Apoptotic process GO:0006915
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
|
2 | P97299 (/IMP) P97299 (/IMP) |
Cell-cell signaling GO:0007267
Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.
|
2 | Q863H1 (/IDA) Q863H1 (/IDA) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
2 | P97299 (/ISO) P97299 (/ISO) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
2 | P97299 (/ISO) P97299 (/ISO) |
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
|
2 | P97299 (/IGI) P97299 (/IGI) |
Anterior/posterior pattern specification GO:0009952
The regionalization process in which specific areas of cell differentiation are determined along the anterior-posterior axis. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.
|
2 | P97299 (/IGI) P97299 (/IGI) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P97299 (/IDA) P97299 (/IDA) |
Negative regulation of cardiac muscle cell apoptotic process GO:0010667
Any process that decreases the rate or extent of cardiac cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a cardiac muscle cell and result in its death.
|
2 | P97299 (/IDA) P97299 (/IDA) |
Negative regulation of epithelial to mesenchymal transition GO:0010719
Any process that decreases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
2 | P97299 (/ISO) P97299 (/ISO) |
Positive regulation of endopeptidase activity GO:0010950
Any process that increases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins.
|
2 | P97299 (/IDA) P97299 (/IDA) |
Regulation of neuron projection development GO:0010975
Any process that modulates the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
2 | P97299 (/IDA) P97299 (/IDA) |
Neural tube development GO:0021915
The process whose specific outcome is the progression of the neural tube over time, from its formation to the mature structure. The mature structure of the neural tube exists when the tube has been segmented into the forebrain, midbrain, hindbrain and spinal cord regions. In addition neural crest has budded away from the epithelium.
|
2 | P97299 (/IGI) P97299 (/IGI) |
Regulation of Wnt signaling pathway GO:0030111
Any process that modulates the frequency, rate or extent of the activity of the Wnt signal transduction pathway.
|
2 | P97299 (/IDA) P97299 (/IDA) |
Negative regulation of Wnt signaling pathway GO:0030178
Any process that stops, prevents, or reduces the frequency, rate or extent of the Wnt signaling pathway.
|
2 | P97299 (/ISO) P97299 (/ISO) |
Collagen fibril organization GO:0030199
Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix.
|
2 | P97299 (/IMP) P97299 (/IMP) |
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
|
2 | P97299 (/IDA) P97299 (/IDA) |
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
|
2 | P97299 (/ISO) P97299 (/ISO) |
Negative regulation of cell migration GO:0030336
Any process that stops, prevents, or reduces the frequency, rate or extent of cell migration.
|
2 | P97299 (/IDA) P97299 (/IDA) |
Negative regulation of BMP signaling pathway GO:0030514
Any process that stops, prevents, or reduces the frequency, rate or extent of the BMP signaling pathway.
|
2 | P97299 (/IDA) P97299 (/IDA) |
Negative regulation of BMP signaling pathway GO:0030514
Any process that stops, prevents, or reduces the frequency, rate or extent of the BMP signaling pathway.
|
2 | P97299 (/IGI) P97299 (/IGI) |
Cellular response to extracellular stimulus GO:0031668
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an extracellular stimulus.
|
2 | P97299 (/IDA) P97299 (/IDA) |
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
|
2 | P97299 (/IDA) P97299 (/IDA) |
Positive regulation of cell adhesion mediated by integrin GO:0033630
Any process that activates or increases the frequency, rate, or extent of cell adhesion mediated by integrin.
|
2 | Q863H1 (/IDA) Q863H1 (/IDA) |
Post-anal tail morphogenesis GO:0036342
The process in which a post-anal tail is generated and organized. A post-anal tail is a muscular region of the body that extends posterior to the anus. The post-anal tail may aid locomotion and balance.
|
2 | P97299 (/IMP) P97299 (/IMP) |
Regulation of cell population proliferation GO:0042127
Any process that modulates the frequency, rate or extent of cell proliferation.
|
2 | P97299 (/IMP) P97299 (/IMP) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
2 | P97299 (/IDA) P97299 (/IDA) |
Negative regulation of mesodermal cell fate specification GO:0042662
Any process that stops, prevents, or reduces the frequency, rate or extent of mesoderm cell fate specification.
|
2 | P97299 (/IGI) P97299 (/IGI) |
Embryonic digit morphogenesis GO:0042733
The process, occurring in the embryo, by which the anatomical structures of the digit are generated and organized. A digit is one of the terminal divisions of an appendage, such as a finger or toe.
|
2 | P97299 (/IMP) P97299 (/IMP) |
Regulation of apoptotic process GO:0042981
Any process that modulates the occurrence or rate of cell death by apoptotic process.
|
2 | P97299 (/IMP) P97299 (/IMP) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
2 | P97299 (/ISO) P97299 (/ISO) |
Negative regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043154
Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process.
|
2 | P97299 (/IDA) P97299 (/IDA) |
Negative regulation of JUN kinase activity GO:0043508
Any process that stops, prevents, or reduces the frequency, rate or extent of JUN kinase activity.
|
2 | P97299 (/IGI) P97299 (/IGI) |
Positive regulation of fat cell differentiation GO:0045600
Any process that activates or increases the frequency, rate or extent of adipocyte differentiation.
|
2 | P97299 (/ISO) P97299 (/ISO) |
Positive regulation of osteoblast differentiation GO:0045669
Any process that activates or increases the frequency, rate or extent of osteoblast differentiation.
|
2 | P97299 (/IGI) P97299 (/IGI) |
Positive regulation of angiogenesis GO:0045766
Any process that activates or increases angiogenesis.
|
2 | P97299 (/IDA) P97299 (/IDA) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | P97299 (/ISO) P97299 (/ISO) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
2 | P97299 (/IDA) P97299 (/IDA) |
Development of primary male sexual characteristics GO:0046546
The process whose specific outcome is the progression of the primary male sexual characteristics over time, from their formation to the mature structures. The primary male sexual characteristics are the testes, and they develop in response to sex hormone secretion.
|
2 | P97299 (/IGI) P97299 (/IGI) |
Digestive tract morphogenesis GO:0048546
The process in which the anatomical structures of the digestive tract are generated and organized. The digestive tract is the anatomical structure through which food passes and is processed.
|
2 | P97299 (/IGI) P97299 (/IGI) |
Negative regulation of epithelial cell proliferation GO:0050680
Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation.
|
2 | P97299 (/ISO) P97299 (/ISO) |
Negative regulation of peptidyl-tyrosine phosphorylation GO:0050732
Any process that stops, prevents, or reduces the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
|
2 | P97299 (/IDA) P97299 (/IDA) |
Cartilage development GO:0051216
The process whose specific outcome is the progression of a cartilage element over time, from its formation to the mature structure. Cartilage elements are skeletal elements that consist of connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
|
2 | P97299 (/IMP) P97299 (/IMP) |
Convergent extension involved in axis elongation GO:0060028
The morphogenetic process in which an epithelium narrows along one axis and lengthens in a perpendicular axis contributing to the lengthening of the axis of an organism.
|
2 | P97299 (/IGI) P97299 (/IGI) |
Bone morphogenesis GO:0060349
The process in which bones are generated and organized.
|
2 | P97299 (/IMP) P97299 (/IMP) |
Sclerotome development GO:0061056
The progression of the sclerotome over time, from its initial formation to the mature structure. The sclerotome is the portion of the somite that will give rise to a vertebra.
|
2 | P97299 (/IEP) P97299 (/IEP) |
Negative regulation of dermatome development GO:0061185
Any process that decreases the rate, frequency, or extent of the progression of the dermatome over time, from its initial formation to the mature structure. The dermatome is the portion of a somite that will form skin.
|
2 | P97299 (/IDA) P97299 (/IDA) |
Hematopoietic stem cell proliferation GO:0071425
The expansion of a hematopoietic stem cell population by cell division. A hematopoietic stem cell is a stem cell from which all cells of the lymphoid and myeloid lineages develop.
|
2 | P97299 (/IDA) P97299 (/IDA) |
Cellular response to X-ray GO:0071481
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of X-ray radiation. An X-ray is a form of electromagnetic radiation with a wavelength in the range of 10 nanometers to 100 picometers (corresponding to frequencies in the range 30 PHz to 3 EHz).
|
2 | P97299 (/IDA) P97299 (/IDA) |
Negative regulation of canonical Wnt signaling pathway GO:0090090
Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
|
2 | P97299 (/ISO) P97299 (/ISO) |
Regulation of establishment of planar polarity GO:0090175
Any process that modulates the rate, frequency or extent of the establishment of planar polarity, the coordinated organization of groups of cells in a tissue, such that they all orient to similar coordinates.
|
2 | P97299 (/IGI) P97299 (/IGI) |
Planar cell polarity pathway involved in neural tube closure GO:0090179
The series of molecular signals initiated by binding of a Wnt protein to a receptor on the surface of the target cell where activated receptors signal via downstream effectors that modulates the establishment of planar polarity contributing to neural tube closure.
|
2 | P97299 (/IGI) P97299 (/IGI) |
Wnt signaling pathway involved in somitogenesis GO:0090244
The series of molecular signals initiated by binding of Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state that contributes to somitogenesis.
|
2 | P97299 (/IGI) P97299 (/IGI) |
Positive regulation of canonical Wnt signaling pathway GO:0090263
Any process that increases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
|
2 | P97299 (/IDA) P97299 (/IDA) |
Positive regulation of canonical Wnt signaling pathway GO:0090263
Any process that increases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
|
2 | P97299 (/ISO) P97299 (/ISO) |
Negative regulation of extrinsic apoptotic signaling pathway via death domain receptors GO:1902042
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.
|
2 | P97299 (/IDA) P97299 (/IDA) |
Negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage GO:1902230
Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to DNA damage.
|
2 | Q863H1 (/IDA) Q863H1 (/IDA) |
Regulation of midbrain dopaminergic neuron differentiation GO:1904956
Any process that modulates the frequency, rate or extent of midbrain dopaminergic neuron differentiation.
|
2 | P97299 (/IGI) P97299 (/IGI) |
Regulation of stem cell division GO:2000035
Any process that modulates the frequency, rate or extent of stem cell division.
|
2 | P97299 (/IDA) P97299 (/IDA) |
Negative regulation of planar cell polarity pathway involved in axis elongation GO:2000041
Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in axis elongation.
|
2 | P97299 (/IGI) P97299 (/IGI) |
Apoptotic process GO:0006915
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
|
1 | Q9IA96 (/TAS) |
Response to nutrient GO:0007584
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
|
1 | B1WBV2 (/IEP) |
Negative regulation of Wnt signaling pathway GO:0030178
Any process that stops, prevents, or reduces the frequency, rate or extent of the Wnt signaling pathway.
|
1 | Q7ZXM6 (/TAS) |
There are 6 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
8 | P97299 (/IDA) P97299 (/IDA) Q863H1 (/IDA) Q863H1 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) Q96HF1 (/IDA) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
4 | Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) |
Collagen-containing extracellular matrix GO:0062023
An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells.
|
4 | Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) Q96HF1 (/ISS) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
2 | P97299 (/TAS) P97299 (/TAS) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
2 | P97299 (/ISO) P97299 (/ISO) |
Collagen-containing extracellular matrix GO:0062023
An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells.
|
2 | Q863H1 (/IDA) Q863H1 (/IDA) |